{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:10:52Z","timestamp":1789053052554,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073838"],"award-info":[{"award-number":["82073838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273917"],"award-info":[{"award-number":["82273917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08670-5","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:46:04Z","timestamp":1784947564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The functional role of the circular RNA circCDR1as targeting SERCA2a in the progression of pathological cardiac hypertrophy and heart failure"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiapan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"8670_CR1","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.124.072661","volume":"151","author":"C Xiao","year":"2025","unstructured":"Xiao C, Wang C, Wang J, Wu X, Ke C, Nan J, Ding H, Xu Y, Shi Y, Zhao J, Ni C, Liu Q, Li J, Sheng S, Chen H, Cai J, Zhao T, Chen J, Sun Q, Zhou B, Wang J, Zhu W, Hu X. FMO2 Prevents Pathological Cardiac Hypertrophy by Maintaining the ER-Mitochondria Association Through Interaction With IP3R2-Grp75-VDAC1. Circulation. 2025;151:1667\u201385.","journal-title":"Circulation"},{"key":"8670_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, Zhang H, Fan Q, Huang C, Xie H, Lu L, Shen W, Ning G, Wang J, Zhang R, Chen K, Yan X. DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics. Circulation. 2022;145:829\u201346.","journal-title":"Circulation"},{"key":"8670_CR3","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89:1401\u201338.","journal-title":"Arch Toxicol"},{"key":"8670_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","volume":"114","author":"HY Seok","year":"2014","unstructured":"Seok HY, Chen J, Kataoka M, Huang ZP, Ding J, Yan J, Hu X, Wang DZ. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy. Circ Res. 2014;114:1585\u201395.","journal-title":"Circ Res"},{"key":"8670_CR5","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1093\/eurheartj\/ehaa519","volume":"41","author":"J Viereck","year":"2020","unstructured":"Viereck J, B\u00fchrke A, Foinquinos A, Chatterjee S, Kleeberger JA, Xiao K, Janssen-Peters H, Batkai S, Ramanujam D, Kraft T, Cebotari S, Gueler F, Beyer AM, Schmitz J, Br\u00e4sen JH, Schmitto JD, Gy\u00f6ngy\u00f6si M, L\u00f6ser A, Hirt MN, Eschenhagen T, Engelhardt S, B\u00e4r C, Thum T. Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy. Eur Heart J. 2020;41:3462\u201374.","journal-title":"Eur Heart J"},{"key":"8670_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11658-023-00520-2","volume":"29","author":"X Fang","year":"2024","unstructured":"Fang X, Ao X, Xiao D, Wang Y, Jia Y, Wang P, Li M, Wang J. Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p\/HSP20 axis. Cell Mol Biol Lett. 2024;29:3.","journal-title":"Cell Mol Biol Lett"},{"key":"8670_CR7","doi-asserted-by":"publisher","first-page":"e07365","DOI":"10.1002\/advs.202507365","volume":"12","author":"J Sheng","year":"2025","unstructured":"Sheng J, Lin Q, Sun Y, Meng Y, Hu S, Cao H, Lin F, Zhu Y, Peng L, Li L. LncRNA Foxo6os as a Novel Scaffold Mediates MYBPC3 in Combating Pathological Cardiac Hypertrophy and Heart Failure. Adv Sci (Weinh). 2025;12:e07365.","journal-title":"Adv Sci (Weinh)"},{"key":"8670_CR8","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/thno.42174","volume":"10","author":"A Huang","year":"2020","unstructured":"Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10:3503\u201317.","journal-title":"Theranostics"},{"key":"8670_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yjmcc.2016.07.007","volume":"98","author":"S Werfel","year":"2016","unstructured":"Werfel S, Nothjunge S, Schwarzmayr T, Strom TM, Meitinger T, Engelhardt S. Characterization of circular RNAs in human, mouse and rat hearts. J Mol Cell Cardiol. 2016;98:103\u20137.","journal-title":"J Mol Cell Cardiol"},{"key":"8670_CR10","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1161\/CIRCRESAHA.124.325573","volume":"136","author":"M Li","year":"2025","unstructured":"Li M, Ding W, Fang X, Wang Y, Wang P, Ye L, Miao S, Song L, Ao X, Li Q, Wang J. Novel Truncated Peptide Derived From circCDYL Exacerbates Cardiac Hypertrophy. Circ Res. 2025;136:e94\u2013112.","journal-title":"Circ Res"},{"key":"8670_CR11","first-page":"0626","volume":"8","author":"W Wang","year":"2025","unstructured":"Wang W, Chen L, Zhao Y, Zhang S, Zhou X. Circ-0001283 Aggravates Cardiac Hypertrophy by Targeting Myosin Light Chain 3 Protein. Res (Wash D C). 2025;8:0626.","journal-title":"Res (Wash D C)"},{"key":"8670_CR12","doi-asserted-by":"publisher","first-page":"115267","DOI":"10.1016\/j.biopha.2023.115267","volume":"165","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang J, Zhao X, Li W, Liu Y, Li X, Zhao D, Yu J, Ji H, Shao B, Li Z, Wang J, Yang Y, Hao Y, Wu Y, Yuan Y, Du Z. CDR1as promotes arrhythmias in myocardial infarction via targeting the NAMPT-NAD(+) pathway. Biomed Pharmacother. 2023;165:115267.","journal-title":"Biomed Pharmacother"},{"key":"8670_CR13","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3724\/abbs.2025126","volume":"57","author":"J Wang","year":"2025","unstructured":"Wang J, Liao W, Li X, Chen Z, Duan C, Wang Z, Li H, Du H, Yuan Y, Du Z. CDR1as modulates arrhythmia post-myocardial infarction via regulating Cav1.2. Acta Biochim Biophys Sin (Shanghai). 2025;57:1780\u201390.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"8670_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00018-025-05960-x","volume":"82","author":"DJ Bare","year":"2025","unstructured":"Bare DJ, Ai X. Stress-Induced calcium mishandling in cardiac (Patho)physiology. Cell Mol Life Sci. 2025;82:437.","journal-title":"Cell Mol Life Sci"},{"key":"8670_CR15","doi-asserted-by":"publisher","first-page":"115241","DOI":"10.1016\/j.colsurfb.2025.115241","volume":"258","author":"S Zhai","year":"2026","unstructured":"Zhai S, Hu N, Wang Z, Zhang H, Guo X, Zhang R. Targeted delivery of calcium antagonist by side-chain selenium containing polymer for cardiac hypertrophy therapy. Colloids Surf B Biointerfaces. 2026;258:115241.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"8670_CR16","doi-asserted-by":"crossref","unstructured":"Liu B, Lou Q, Smith H, Velez-Cortes F, Dillmann WH, Knollmann BC, Armoundas AA, Gy\u00f6rke S. Conditional up-regulation of SERCA2a exacerbates RyR2-dependent ventricular and atrial arrhythmias. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21072535"},{"key":"8670_CR17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s44161-025-00699-x","volume":"4","author":"Y Nakada","year":"2025","unstructured":"Nakada Y, Titus AS, Mizushima W, Yang Y, Zhai P, Tian Y, Oka S, Kashihara T, Fefelova N, Pamarthi SH, Liu T, Li H, Xie LH, Takayama K, Ikeda S, Matsushita M, Huang CY, Hsu CP, Onoue K, Saito Y, Sadoshima J. p22(phox) prevents the oxidation of SERCA2a and stabilizes it in the heart. Nat Cardiovasc Res. 2025;4:1187\u2013205.","journal-title":"Nat Cardiovasc Res"},{"key":"8670_CR18","doi-asserted-by":"publisher","first-page":"pgaf045","DOI":"10.1093\/pnasnexus\/pgaf045","volume":"4","author":"E Bovo","year":"2025","unstructured":"Bovo E, Nikolaienko R, Kahn D, Espinoza-Fonseca LM, Zima AV. The endoplasmic reticulum luminal Ca(2+) regulates cardiac Ca(2+) pump function. PNAS Nexus. 2025;4:pgaf045.","journal-title":"PNAS Nexus"},{"key":"8670_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.119.12998","volume":"74","author":"B Cai","year":"2019","unstructured":"Cai B, Zhang Y, Zhao Y, Wang J, Li T, Zhang Y, Jiang Y, Jin X, Xue G, Li P, Sun Y, Huang Q, Zhang X, Su W, Yang Y, Sun Y, Shi L, Li X, Lu Y, Yang B, Pan Z. Long Noncoding RNA-DACH1 (Dachshund Homolog 1) Regulates Cardiac Function by Inhibiting SERCA2a (Sarcoplasmic Reticulum Calcium ATPase 2a). Hypertension. 2019;74:833\u201342.","journal-title":"Hypertension"},{"key":"8670_CR20","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCRESAHA.117.312117","volume":"122","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Jiao L, Sun L, Li Y, Gao Y, Xu C, Shao Y, Li M, Li C, Lu Y, Pan Z, Xuan L, Zhang Y, Li Q, Yang R, Zhuang Y, Zhang Y, Yang B. LncRNA ZFAS1 as a SERCA2a Inhibitor to Cause Intracellular Ca(2+) Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction. Circ Res. 2018;122:1354\u201368.","journal-title":"Circ Res"},{"key":"8670_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00018-025-05915-2","volume":"82","author":"W Pan","year":"2025","unstructured":"Pan W, Hunkler HJ, Chatterjee S, Lu D, Riedel I, Gietz A, Xiao K, Fuchs M, Neufeldt D, Kraft T, Huang CK, Cushman S, B\u00fchrke A, Schmidt A, Mohr E, Weber N, B\u00e4r C, Thum T. A circular RNA derived from the ryanodine receptor 2 locus controls cardiac hypertrophy and calcium handling. Cell Mol Life Sci. 2025;82:359.","journal-title":"Cell Mol Life Sci"},{"key":"8670_CR22","doi-asserted-by":"publisher","first-page":"103563","DOI":"10.1016\/j.redox.2025.103563","volume":"81","author":"J Fu","year":"2025","unstructured":"Fu J, Su C, Ge Y, Ao Z, Xia L, Chen Y, Yang Y, Chen S, Xu R, Yang X, Huang K, Fu Q. PDE4D inhibition ameliorates cardiac hypertrophy and heart failure by activating mitophagy. Redox Biol. 2025;81:103563.","journal-title":"Redox Biol"},{"key":"8670_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/CIRCRESAHA.123.324110","volume":"135","author":"V Mallaredy","year":"2024","unstructured":"Mallaredy V, Roy R, Cheng Z, Thej C, Benedict C, Truongcao M, Joladarashi D, Magadum A, Ibetti J, Cimini M, Gonzalez C, Garikipati VNS, Koch WJ, Kishore R. Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure. Circ Res. 2024;135:280\u201397.","journal-title":"Circ Res"},{"key":"8670_CR24","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1038\/s41467-023-43167-5","volume":"14","author":"HC Chen","year":"2023","unstructured":"Chen HC, Liu YW, Chang KC, Wu YW, Chen YM, Chao YK, You MY, Lundy DJ, Lin CJ, Hsieh ML, Cheng YC, Prajnamitra RP, Lin PJ, Ruan SC, Chen DH, Shih ESC, Chen KW, Chang SS, Chang CMC, Puntney R, Moy AW, Cheng YY, Chien HY, Lee JJ, Wu DC, Hwang MJ, Coonen J, Hacker TA, Yen CE, Rey FE, Kamp TJ, Hsieh PCH. Gut butyrate-producers confer post-infarction cardiac protection. Nat Commun. 2023;14:7249.","journal-title":"Nat Commun"},{"key":"8670_CR25","doi-asserted-by":"crossref","unstructured":"Chen Z, Zhong Y, Chen L, Liu W, Lin C, Chen Y, Wang X. HGF aggravated periodontitis-associated gut barrier and microbial dysfunction: implications for oral-gut axis regulation. Biology (Basel). 2025;14.","DOI":"10.3390\/biology14050496"},{"key":"8670_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/0023677217738268","volume":"52","author":"MF Festing","year":"2018","unstructured":"Festing MF. On determining sample size in experiments involving laboratory animals. Lab Anim. 2018;52:341\u201350.","journal-title":"Lab Anim"},{"key":"8670_CR27","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1093\/eurheartj\/ehaf1116","volume":"47","author":"M Jung","year":"2026","unstructured":"Jung M, Schmidt A, Sansonetti M, Al Soodi B, Thum S, Pfanne A, Just A, Xiao K, Huang CK, Erschow S, Ricke-Hoch M, Oehlsen L, Agyapong W, Jansen K, Blume J, B\u00fcchler G, Hilbold E, B\u00e4r C, Weber N, Schinke M, Nguyen AHH, Wollert KC, Thackeray JT, Bengel F, Lachmann N, Thum T. Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction. Eur Heart J. 2026;47:2831\u201347.","journal-title":"Eur Heart J"},{"key":"8670_CR28","doi-asserted-by":"publisher","first-page":"106284","DOI":"10.1016\/j.phrs.2022.106284","volume":"182","author":"X Li","year":"2022","unstructured":"Li X, Zhang Y, Zhao Y, Zhou Y, Han Q, Yang Y, Zhang L, Shi L, Jin X, Zhang R, Gao H, Xue G, Li D, Zhang ZR, Lu Y, Yang B, Pan Z. Cullin-associated and neddylation-dissociated 1 protein (CAND1) governs cardiac hypertrophy and heart failure partially through regulating calcineurin degradation. Pharmacol Res. 2022;182:106284.","journal-title":"Pharmacol Res"},{"key":"8670_CR29","doi-asserted-by":"publisher","first-page":"e2308769","DOI":"10.1002\/advs.202308769","volume":"11","author":"S Yu","year":"2024","unstructured":"Yu S, Sun Z, Ju T, Liu Y, Mei Z, Wang C, Qu Z, Li N, Wu F, Liu K, Lu M, Huang M, Pang X, Jia Y, Li Y, Zhang Y, Dou S, Jiang J, Dong X, Huang C, Li W, Zhang Y, Yuan Y, Yang B, Du W. The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4. Adv Sci (Weinh). 2024;11:e2308769.","journal-title":"Adv Sci (Weinh)"},{"key":"8670_CR30","doi-asserted-by":"crossref","unstructured":"Li X, Zhang L, Tian T, Pei Y, Wang K, Wang S, Ning X, Zhao P, Qu Y, Gao H, Li C, Liu X, Yang J, Zhang Y, Gao H, Xuan L, Zhang Y, Lu Y, Cai B, Yang B, Pan Z. Cullin-associated and neddylation-dissociated protein 1 (CAND1) promotes cardiomyocyte proliferation and heart regeneration by enhancing the ubiquitinated degradation of Mps one binder kinase activator 1b (Mob1b). Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01540-5"},{"key":"8670_CR31","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41401-020-00580-6","volume":"42","author":"GL Xue","year":"2021","unstructured":"Xue GL, Li DS, Wang ZY, Liu Y, Yang JM, Li CZ, Li XD, Ma JD, Zhang MM, Lu YJ, Li Y, Yang BF, Pan ZW. Interleukin-17 upregulation participates in the pathogenesis of heart failure in mice via NF-\u03baB-dependent suppression of SERCA2a and Cav1.2 expression. Acta Pharmacol Sin. 2021;42:1780\u201389.","journal-title":"Acta Pharmacol Sin"},{"key":"8670_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s11427-023-2527-5","volume":"67","author":"H Yang","year":"2024","unstructured":"Yang H, Xuan L, Wang S, Luo H, Duan X, Guo J, Cui S, Xin J, Hao J, Li X, Chen J, Sun F, Hu X, Li S, Zhang Y, Jiao L, Yang B, Sun L. LncRNA CCRR maintains Ca(2+) homeostasis against myocardial infarction through the FTO-SERCA2a pathway. Sci China Life Sci. 2024;67:1601\u201319.","journal-title":"Sci China Life Sci"},{"key":"8670_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, Han J, Han X, Huang W, Wu G, Wang X, Liang G. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circ Res. 2023;132:465\u201380.","journal-title":"Circ Res"},{"key":"8670_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","volume":"24","author":"JC Christianson","year":"2023","unstructured":"Christianson JC, Jarosch E, Sommer T. Mechanisms of substrate processing during ER-associated protein degradation. Nat Rev Mol Cell Biol. 2023;24:777\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8670_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther. 2022;7:113.","journal-title":"Signal Transduct Target Ther"},{"key":"8670_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-021-04208-3","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Li Q, Zhao G, Zhang J, Yuan H, Feng T, Ou D, Gu R, Li S, Li K, Lin P. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell Death Dis. 2021;12:945.","journal-title":"Cell Death Dis"},{"key":"8670_CR37","doi-asserted-by":"publisher","first-page":"116597","DOI":"10.1016\/j.bcp.2024.116597","volume":"230","author":"F Liu","year":"2024","unstructured":"Liu F, Lv LF, Bi FF, Pan QM, Jing ZH, Cui C, Cao M, Yu T, Li J, He YJ, Xiao HW, Tian H, Wu Y, Shan HL, Zhou YH. ITFG2 as a NEDD4-2 inhibitor: Preserving calcium homeostasis to prevent myocardial ischemic injury. Biochem Pharmacol. 2024;230:116597.","journal-title":"Biochem Pharmacol"},{"key":"8670_CR38","doi-asserted-by":"publisher","first-page":"e12185","DOI":"10.1002\/jev2.12185","volume":"11","author":"X Yu","year":"2022","unstructured":"Yu X, Bai Y, Han B, Ju M, Tang T, Shen L, Li M, Yang L, Zhang Z, Hu G, Chao J, Zhang Y, Yao H. Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours. J Extracell Vesicles. 2022;11:e12185.","journal-title":"J Extracell Vesicles"},{"key":"8670_CR39","doi-asserted-by":"publisher","first-page":"114039","DOI":"10.1016\/j.jconrel.2025.114039","volume":"385","author":"M Li","year":"2025","unstructured":"Li M, Jia X, Lai P, Ma Y, Li F, Yang L, Zhang S, Yang C, Luo Y, Wang Q. Injectable microenvironment-responsive hydrogels encapsulating engineered NF-\u03baB-targeting circular RNA for osteoarthritis therapy. J Control Release. 2025;385:114039.","journal-title":"J Control Release"},{"key":"8670_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","volume":"8","author":"D Niu","year":"2023","unstructured":"Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Ther. 2023;8:341.","journal-title":"Signal Transduct Target Ther"},{"key":"8670_CR41","doi-asserted-by":"publisher","first-page":"174915","DOI":"10.1016\/j.ejphar.2022.174915","volume":"922","author":"Y Shao","year":"2022","unstructured":"Shao Y, Li M, Yu Q, Gong M, Wang Y, Yang X, Liu L, Liu D, Tan Z, Zhang Y, Qu Y, Li H, Wang Y, Jiao L, Zhang Y. CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy. Eur J Pharmacol. 2022;922:174915.","journal-title":"Eur J Pharmacol"},{"key":"8670_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/gtmb.2020.0034","volume":"24","author":"C Chen","year":"2020","unstructured":"Chen C, Shen H, Huang Q, Li Q. The Circular RNA CDR1as Regulates the Proliferation and Apoptosis of Human Cardiomyocytes Through the miR-135a\/HMOX1 and miR-135b\/HMOX1 Axes. Genet Test Mol Biomarkers. 2020;24:537\u201348.","journal-title":"Genet Test Mol Biomarkers"},{"key":"8670_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/CIRCRESAHA.125.326377","volume":"137","author":"C Gonzalez","year":"2025","unstructured":"Gonzalez C, Cimini M, Mallaredy V, Benedict C, Joladarashi D, Thej C, Cheng Z, Trungcao M, Rai AK, Garikipati VNS, Kishore R. Circular RNA Cdr1as Modulates Macrophage-Mediated Cardiac Reparative Function. Circ Res. 2025;137:1207\u201321.","journal-title":"Circ Res"},{"key":"8670_CR44","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s42255-020-00276-5","volume":"2","author":"M Fernandez-Caggiano","year":"2020","unstructured":"Fernandez-Caggiano M, Kamynina A, Francois AA, Prysyazhna O, Eykyn TR, Krasemann S, Crespo-Leiro MG, Vieites MG, Bianchi K, Morales V, Domenech N, Eaton P. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. Nat Metab. 2020;2:1223\u201331.","journal-title":"Nat Metab"},{"key":"8670_CR45","doi-asserted-by":"publisher","first-page":"103081","DOI":"10.1016\/j.redox.2024.103081","volume":"70","author":"M Abudureyimu","year":"2024","unstructured":"Abudureyimu M, Luo X, Jiang L, Jin X, Pan C, Yu W, Ge J, Zhang Y, Ren J. FBXL4 protects against HFpEF through Drp1-Mediated regulation of mitochondrial dynamics and the downstream SERCA2a. Redox Biol. 2024;70:103081.","journal-title":"Redox Biol"},{"key":"8670_CR46","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.120.053365","volume":"144","author":"M Korf-Klingebiel","year":"2021","unstructured":"Korf-Klingebiel M, Reboll MR, Polten F, Weber N, J\u00e4ckle F, Wu X, Kallikourdis M, Kunderfranco P, Condorelli G, Giannitsis E, Kustikova OS, Schambach A, Pich A, Widder JD, Bauersachs J, van den Heuvel J, Kraft T, Wang Y, Wollert KC. Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco\/Endoplasmic Reticulum Ca(2+)-ATPase Expression in Cardiomyocytes. Circulation. 2021;144:1227\u201340.","journal-title":"Circulation"},{"key":"8670_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/cvr\/cvad178","volume":"120","author":"P Lai","year":"2024","unstructured":"Lai P, Hille SS, Subramanian H, Wiegmann R, Roser P, M\u00fcller OJ, Nikolaev VO, De Jong KA. Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes. Cardiovasc Res. 2024;120:273\u201385.","journal-title":"Cardiovasc Res"},{"key":"8670_CR48","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/mt.2015.158","volume":"23","author":"S Yl\u00e4-Herttuala","year":"2015","unstructured":"Yl\u00e4-Herttuala S. Gene Therapy for Heart Failure: Back to the Bench. Mol Ther. 2015;23:1551\u20132.","journal-title":"Mol Ther"},{"key":"8670_CR49","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1161\/CIRCRESAHA.119.316061","volume":"127","author":"D Han","year":"2020","unstructured":"Han D, Wang Y, Wang Y, Dai X, Zhou T, Chen J, Tao B, Zhang J, Cao F. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a. Circ Res. 2020;127:e108\u201325.","journal-title":"Circ Res"},{"key":"8670_CR50","doi-asserted-by":"publisher","first-page":"e2406318","DOI":"10.1002\/advs.202406318","volume":"11","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lin P, Lu Y, Zheng J, Zheng Y, Huang X, Zhao X, Cui L. Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. Adv Sci (Weinh). 2024;11:e2406318.","journal-title":"Adv Sci (Weinh)"},{"key":"8670_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, Jia X, Dong Z, Liu K. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"8670_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19:146.","journal-title":"Mol Cancer"},{"key":"8670_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-020-01253-y","volume":"19","author":"J Lou","year":"2020","unstructured":"Lou J, Hao Y, Lin K, Lyu Y, Chen M, Wang H, Zou D, Jiang X, Wang R, Jin D, Lam EW, Shao S, Liu Q, Yan J, Wang X, Chen P, Zhang B, Jin B. Circular RNA CDR1as disrupts the p53\/MDM2 complex to inhibit Gliomagenesis. Mol Cancer. 2020;19:138.","journal-title":"Mol Cancer"},{"key":"8670_CR54","doi-asserted-by":"publisher","first-page":"e2406962","DOI":"10.1002\/advs.202406962","volume":"12","author":"C Zhang","year":"2025","unstructured":"Zhang C, Tian C, Zhu R, Chen C, Jin C, Wang X, Sun L, Peng W, Ji D, Zhang Y, Sun Y. CircSATB1 Promotes Colorectal Cancer Liver Metastasis through Facilitating FKBP8 Degradation via RNF25-Mediated Ubiquitination. Adv Sci (Weinh). 2025;12:e2406962.","journal-title":"Adv Sci (Weinh)"},{"key":"8670_CR55","first-page":"943","volume":"22","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Harooni E, Amraei M, Aghaei M, Fard RM. Closer look at circulating nitric oxide levels and their association with polycystic ovary syndrome: A meta-analytical exploration. Int J Reprod Biomed. 2024;22:943\u201362.","journal-title":"Int J Reprod Biomed"},{"key":"8670_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13098-025-01849-8","volume":"17","author":"R Mohammadpour Fard","year":"2025","unstructured":"Mohammadpour Fard R, Sherafat NS, Rashno M, Bahreiny SS. Evaluating pentraxin 3 as a diagnostic biomarker for diabetic retinopathy: a systematic review and meta-analysis. Diabetol Metab Syndr. 2025;17:273.","journal-title":"Diabetol Metab Syndr"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08670-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08670-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:57:07Z","timestamp":1789052227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08670-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8670"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08670-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal protocols were approved by the Institutional Animal Care and Use Committee and the Ethics Committee of Harbin Medical University (No. sydwgzr2020-153-01), complying with NIH animal care guidelines. The research on human serum samples was performed in strict accordance with the Declaration of Helsinki which has been approved by the ethical review committee of the Second Affiliated Hospital of Harbin Medical University (approval No. ky2020-049-01).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1170"}}